Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Launched by INDIANA UNIVERSITY · May 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a device called TEG 6s, which helps doctors understand how well blood is clotting in children. The main goal is to find out what normal results look like for healthy kids and see how these compare to existing data. By learning more about how the TEG 6s works in pediatric patients, researchers hope to improve care for children who may have issues with blood clotting in the future.

To be part of this study, children must be under 18 years old and scheduled for an elective surgery at Riley Hospital for Children. It’s important to note that kids with known blood clotting disorders or those taking certain medications that affect blood clotting cannot participate. Participants will provide a small blood sample at the start of their surgery, which will be analyzed using the TEG 6s machine. This study is still looking for volunteers, and it could help doctors better understand blood clotting in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -Patients less than 18 years of age undergoing elective pediatric surgical care in the operating room at Riley Hospital for Children
• Exclusion Criteria:
• • Known disorder of coagulation pathway(s)
• • Administration of medications that may alter the coagulation cascade
• • Patients in foster care or wards of the court